RSV booster study shows promise for older adults

NCT ID NCT07117487

First seen Feb 02, 2026 · Last updated May 14, 2026 · Updated 21 times

Summary

This study tested a booster dose of the experimental mRNA-1345 RSV vaccine in 507 adults aged 60 and older who had already received a licensed RSV vaccine at least 12 months earlier. The goal was to see if the booster was safe and boosted the body's immune defenses against RSV. Researchers measured side effects and antibody levels in the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Indago Research & Health Center, Inc.

    Hialeah, Florida, 33012, United States

  • Velocity Clinical Research, Austin

    Austin, Texas, 78759, United States

  • Velocity Clinical Research, Covington

    Covington, Louisiana, 70433, United States

  • Velocity Clinical Research, Denver

    Denver, Colorado, 80110, United States

  • Velocity Clinical Research, Hampton

    Hampton, Virginia, 23666, United States

  • Velocity Clinical Research, Lincoln

    Lincoln, Nebraska, 68510, United States

  • Velocity Clinical Research, Medford

    Medford, Oregon, 97504, United States

  • Velocity Clinical Research, Rockville

    Rockville, Maryland, 20854, United States

  • Velocity Clinical Research, Savannah

    Savannah, Georgia, 31406, United States

  • Velocity Clinical Research, Spokane

    Spokane, Washington, 99218, United States

  • Velocity Clinical Research, Valparaiso

    Valparaiso, Indiana, 46383, United States

Conditions

Explore the condition pages connected to this study.